Postpartum adiponectin changes in women with gestational diabetes

Area of Science:

• Endocrinology
• Metabolic Disorders
• Reproductive Medicine

Background:

• Gestational diabetes mellitus (GDM) is a common pregnancy complication with unclear long-term metabolic implications.
• Contradictory findings exist regarding adiponectin (AdipoQ) levels in GDM and postpartum.
• AdipoQ is an adipokine with insulin-sensitizing properties, potentially playing a role in glucose homeostasis.

Purpose of the Study:

• To investigate adiponectin (AdipoQ) concentrations in women with GDM during pregnancy and at 3 and 12 months postpartum.
• To compare AdipoQ levels between GDM diagnosis and postpartum follow-up.
• To explore the relationship between AdipoQ levels and glucose metabolism markers post-delivery.

Main Methods:

• Prospective study of 50 women diagnosed with GDM.
• Serum AdipoQ levels measured at GDM diagnosis, 3 months, and 12 months postpartum.
• Clinical and laboratory evaluations including fasting glucose, insulin, OGTT, and lipid profiles performed at all time points.

Main Results:

• AdipoQ concentrations showed no significant difference during gestation or at 3 months postpartum.
• A significant increase in AdipoQ levels was observed at 12 months postpartum compared to pregnancy levels (p=0.0006).
• At 12 months postpartum, AdipoQ inversely correlated with fasting glucose (r=-0.37) and 2-hour post-OGTT glucose (r=-0.42) in the GDM group.

Conclusions:

• Increased AdipoQ levels postpartum in women with GDM may signify reversibility of carbohydrate metabolism disorders.
• The negative correlation between AdipoQ and glucose levels suggests AdipoQ could be a future predictor of glucose tolerance disturbances in women with GDM.